The FDA wants to place warning labels on food packages to combat obesity and other health conditions
The Food and Drug Administration (FDA) is looking to propose the inclusion of front-of-package warning labels that detail the ...
FDA to propose new food label warnings to combat obesity
The FDA is considering food labels to help consumers identify products with unhealthy ingredients, but some experts wonder if ...
STAT9h
FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of key documents
FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...
USA Today15d
FDA approved new COVID-19 vaccines. Here's what to know and where to get them
The U.S. Food and Drug Administration recently green-lit new 2024-25 COVID-19 vaccinations ahead of the fall and winter ...
Food Safety News4d
FDA warns food companies for violations in acidified foods and seafood imports
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
ELAN : FDA Oks Zenrelia, Once-Daily Oral JAK Inhibitor For Dogs With Allergic And Atopic Dermatitis
Elanco Animal Health Inc. (ELAN) announced the U.S. Food and Drug Administration has approved Zenrelia, a convenient once-daily oral ...
Scientific American11h
Obesity-Drug Pioneers Win Prestigious Lasker Award for Medical Science
Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?
USA Today4d
New eczema drug from Eli Lilly receives FDA approval for children and adults
On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 ...
Bone marrow cancer drug shows success in treatment of blood disorder, finds study
When researchers discovered enough proof that a medication used to treat bone marrow cancer and Kaposi sarcoma is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare ...
Asia One5d
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and ...